210 related articles for article (PubMed ID: 1385275)
1. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report.
Garavelli PL
Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275
[No Abstract] [Full Text] [Related]
2. Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia.
Clumeck N; Wit SD; Hermans P; Franchioly P; Sommereijns B
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():353-6. PubMed ID: 1284305
[No Abstract] [Full Text] [Related]
3. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
van der Wouw PA; van Leeuwen R; van Oers RH; Lange JM; Danner SA
Br J Haematol; 1991 Jul; 78(3):319-24. PubMed ID: 1714756
[TBL] [Abstract][Full Text] [Related]
4. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
Garavelli PL; Berti P
Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
Levine JD; Allan JD; Tessitore JH; Falcone N; Galasso F; Israel RJ; Groopman JE
Blood; 1991 Dec; 78(12):3148-54. PubMed ID: 1742482
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS.
Kimura S; Matsuda J; Ikematsu S; Miyazono K; Ito A; Nakahata T; Minamitani M; Shimada K; Shiokawa Y; Takaku F
AIDS; 1990 Dec; 4(12):1251-5. PubMed ID: 1708265
[TBL] [Abstract][Full Text] [Related]
7. [Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)].
Schwander S; Kern P
Med Klin (Munich); 1993 Feb; 88(2):60-2. PubMed ID: 7680750
[No Abstract] [Full Text] [Related]
8. [Granulocyte colony-stimulating factor in a patient with toxic neutropenia and acquired immunodeficiency syndrome].
Alba D; Ripoll MM; Rodríguez MD; Molina F
Med Clin (Barc); 1992 Jul; 99(6):235-6. PubMed ID: 1380622
[No Abstract] [Full Text] [Related]
9. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
Miles SA; Mitsuyasu RT; Moreno J; Baldwin G; Alton NK; Souza L; Glaspy JA
Blood; 1991 May; 77(10):2109-17. PubMed ID: 1709368
[TBL] [Abstract][Full Text] [Related]
10. No antibodies to granulocyte macrophage colony-stimulating factor with prolonged use in AIDS.
Scadden DT; Agosti J
AIDS; 1993 Mar; 7(3):438. PubMed ID: 8471211
[No Abstract] [Full Text] [Related]
11. [Current developments in the treatment of AIDS].
Mulder JW
Ned Tijdschr Geneeskd; 1989 Aug; 133(33):1664-6. PubMed ID: 2477718
[No Abstract] [Full Text] [Related]
12. The use of growth hematopoietic factors in AIDS.
Groopman JE
Pathol Biol (Paris); 1992 Nov; 39(9):874-5. PubMed ID: 1371606
[No Abstract] [Full Text] [Related]
13. [Granulocyte colony-stimulating factor in the treatment of neutropenia associated with HIV infection].
Moreno García M; Fernández González F; Fernández Rodríguez E; Portús de Marco MV
Med Clin (Barc); 1996 Jul; 107(6):237-8. PubMed ID: 8755453
[No Abstract] [Full Text] [Related]
14. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
[TBL] [Abstract][Full Text] [Related]
15. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
[No Abstract] [Full Text] [Related]
16. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
Moreno García M; Fernández González F
Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
[No Abstract] [Full Text] [Related]
17. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
18. Hematologic toxicity of zidovudine in HIV-infected patients.
Brogan KL; Zell SC
Am Fam Physician; 1990 May; 41(5):1521-8. PubMed ID: 1692180
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
Hewitt RG; Morse GD
Pharmacotherapy; 1992; 12(6):455-61. PubMed ID: 1492010
[TBL] [Abstract][Full Text] [Related]
20. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
